Skip to main content

The Cigna Group (CI) Stock Analysis

Momentum Cont setup

SellModerate Confidence

Healthcare · Healthcare Plans

Earnings in 0 days (2026-04-30). Expect elevated volatility around the report — consider waiting for post-earnings price action before new entries.

Sell if holding. Engine safety override at $291.43: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: Below-average business quality.

The Cigna Group is a global health company with two segments: Evernorth Health Services (pharmacy benefit, specialty, and care services) and Cigna Healthcare (U.S. and international health benefits). It serves 185 million customer relationships in 30-plus markets with... Read more

$291.43+4.4% A.UpsideScore 5.4/10#4 of 11 Healthcare Plans
Stop $276.91Target $304.46(analyst − 10%)A.R:R 0.5:1
Analyst target$338.29+16.1%24 analysts
$304.46our TP
$291.43price
$338.29mean
$378

Sell if holding. Engine safety override at $291.43: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: Below-average business quality. Chart setup: Trend continuation, RSI 69, MACD bullish. Score 5.4/10, moderate confidence.

Passes 4/7 gates (positive momentum, clean insider activity, no SEC red flags, semi cycle peak clear). Fails on favorable risk/reward ratio and earnings proximity 0d<=7d. Suitability: moderate.

Thesis

Rewards
No bull case signals
Risks
Quality below floor (3.9 < 4.0)

Key Metrics

P/E (TTM)13.2
P/E (Fwd)8.7
Mkt Cap$77.1B
EV/EBITDA8.3
Profit Mgn2.2%
ROE15.1%
Rev Growth10.4%
Beta0.27
Dividend2.13%
Rating analysts34

Quality Signals

Piotroski F6/9

Options Flow

P/C0.83neutral
IV44%normal
Max Pain$185-36.5% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMCustomertop-10 retail pharmacy chains47%
    10-K Item 1A: 'The 10 largest retail pharmacy chains represent approximately 47% of the total number of stores in our largest network.'

Material Events(8-K, last 90d)

  • 2026-03-03Item 5.02MEDIUM
    CEO succession: Brian Evanko appointed CEO eff. July 1, 2026. David Cordani retires as CEO and becomes Executive Chair. Named successor with clean transition; no disagreement cited.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

3 floor-breakers

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
0.1
Revenue Growth
5.1

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
0.7
52w Position
7.0

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin
0.0
Net Margin
1.1
Operating Margin
1.4
Roa
2.7
Current Ratio
3.4
Roe
5.0
Moat
5.0
Piotroski F
6.7
Fcf Quality
10.0
Excellent cash conversion: 164% FCF/NINo competitive moat
GatesA.R:R 0.5 < 1.5@spotEARNINGS PROXIMITY 0d<=7dDeath cross (50MA < 200MA)Momentum 6.6>=5.5Insider activity: OKNo SEC red flagsSEMI CYCLE PEAK CLEARMomentum ContSuitability: Moderate
RSI
69 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $264.89Resistance $293.77

Price Targets

$277
$304
A.Upside+4.5%
A.R:R0.5:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Quality below floor (3.9 < 4.0)
! Reward/Risk 0.5:1 at current price — below 1.5:1 minimum
! EARNINGS_PROXIMITY:0d<=7d

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-04-30 (0d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CI stock a buy right now?

Sell if holding. Engine safety override at $291.43: Quality below floor (3.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.4/10. Specifically: Below-average business quality. Chart setup: Trend continuation, RSI 69, MACD bullish. Prior stop was $276.91. Score 5.4/10, moderate confidence.

What is the CI stock price target?

Take-profit target: $304.46 (+4.4% upside). Prior stop was $276.91. Stop-loss: $276.91.

What are the risks of investing in CI?

Quality below floor (3.9 < 4.0).

Is CI overvalued or undervalued?

The Cigna Group trades at a P/E of 13.2 (forward 8.7). TrendMatrix value score: 7.9/10. Verdict: Sell.

What do analysts say about CI?

34 analysts cover CI with a consensus score of 4.2/5. Average price target: $338.

What does The Cigna Group do?The Cigna Group is a global health company with two segments: Evernorth Health Services (pharmacy benefit, specialty,...

The Cigna Group is a global health company with two segments: Evernorth Health Services (pharmacy benefit, specialty, and care services) and Cigna Healthcare (U.S. and international health benefits). It serves 185 million customer relationships in 30-plus markets with approximately 67,700 employees.

Related stocks: CVS (CVS Health Corporation) · CNC (Centene Corporation) · HUM (Humana Inc.) · ELV (Elevance Health, Inc.) · UNH (UnitedHealth Group Incorporated)